← Back to patent-cliff list
Diganan cross-linked sodium hyaluronate
Tier C — Watch / tradeDiganan cross-linked sodium hyaluronate
Lg Chemical Ltd
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Hyaluronic acid
Brand：Hyruan ONE, Synovian, DurolaneTM
Indications (approved)：Osteoarthritis
Regional status
US
-
EU
-
China
Approved
2023-03-28
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Diganan cross-linked sodium hyaluronate?
Approved indications include: Osteoarthritis.
When does the Diganan cross-linked sodium hyaluronate patent expire?
No public expiry year is available for Diganan cross-linked sodium hyaluronate yet; this page updates once verified.
How do I get a quote for Diganan cross-linked sodium hyaluronate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29